Provectus Biopharmaceuticals, Inc. SEC filings PVCT
Provectus Biopharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 30, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 23, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 10, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 3, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 18, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 26, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 22, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 23, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Other events
|
Apr 21, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 4, 2026 |
| 4 | Insider transaction | Mar 26, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Jan 29, 2026 | Jan 28, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 5, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Dec 8, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 1, 2025 | — |
| 4 | Insider transaction | Nov 28, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 31, 2025 | Oct 30, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 17, 2025 | Oct 16, 2025 |
| 4 | Insider transaction | Oct 14, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 9, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 19, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 19, 2025 | Sep 18, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Aug 29, 2025 | Aug 29, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 22, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Jul 21, 2025 | Jul 18, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2025 | Jun 18, 2025 |
| DEFA14A | Additional proxy material | Jun 18, 2025 | — |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 10-K/A | Amended annual report | May 16, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | May 5, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | May 2, 2025 | Apr 29, 2025 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 29, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 19, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 16, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 4, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 27, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 20, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 22, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Dec 28, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 26, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 5, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 6, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Sep 20, 2024 | Sep 19, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 29, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2024 | Aug 14, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 14, 2024 | — |
| 4 | Insider transaction | Aug 14, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 9, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 3, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jul 22, 2024 | Jul 20, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 18, 2024 |
| D | Filing | Jul 17, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 17, 2024 | Jul 11, 2024 |
| SC 13D | Ownership over 5% (active) | Jul 3, 2024 | — |
| 4 | Insider transaction | Jul 2, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Jun 25, 2024 | Jun 21, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| 4 | Insider transaction | Jun 17, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 26, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 12, 2024 |
| ARS | Annual report to shareholders | May 9, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | May 6, 2024 |
| 4 | Insider transaction | Apr 30, 2024 | Apr 29, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 26, 2024 | Apr 25, 2024 |
| 4 | Insider transaction | Apr 22, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 16, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Apr 15, 2024 | Apr 11, 2024 |
| 4 | Insider transaction | Apr 9, 2024 | Apr 6, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 27, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2024 | Mar 25, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 17, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 22, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 17, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 2, 2024 |
| 4 | Insider transaction | Feb 1, 2024 | Jan 30, 2024 |
| 4 | Insider transaction | Jan 29, 2024 | Jan 26, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Dec 29, 2023 | Dec 28, 2023 |
| 4 | Insider transaction | Dec 22, 2023 | Dec 22, 2023 |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Dec 2, 2023 |
| 4 | Insider transaction | Nov 30, 2023 | Nov 29, 2023 |
| 4 | Insider transaction | Nov 15, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 4 | Insider transaction | Nov 13, 2023 | Nov 8, 2023 |
| 4 | Insider transaction | Nov 1, 2023 | Nov 1, 2023 |
| 4 | Insider transaction | Oct 27, 2023 | Oct 27, 2023 |
| 4 | Insider transaction | Oct 19, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 5, 2023 | Sep 1, 2022 |
| 4 | Insider transaction | Aug 14, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Aug 4, 2023 | Aug 3, 2023 |
| 4 | Insider transaction | Jul 28, 2023 | Jul 28, 2023 |
| 4 | Insider transaction | Jul 26, 2023 | Jul 24, 2023 |
| 4 | Insider transaction | Jul 24, 2023 | Jul 20, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| DEFA14A | Additional proxy material | Jun 21, 2023 | — |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVCT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Knoxville, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 315545
- Former names
- PROVECTUS PHARMACEUTICALS INC (until Dec 18, 2013); PROVECTUS PHARMACEUTICAL INC (until May 15, 2002); ZAMAGE DIGITAL IMAGING INC (until Apr 1, 2002); SPM GROUP INC (until Nov 14, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.